Announcements Trials
Browse Landscape

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Ovarian Neoplasms 3Neoplasms 2Kenny-Caffey syndrome, Type 1 1

Interventions

Surveys and Questionnaires 22Blood Specimen Collection 13niraparib 8Cytoreduction Surgical Procedures 8Hyperthermic Intraperitoneal Chemotherapy 7Interviews as Topic 6Immunohistochemistry 6olaparib 5Psychiatric Rehabilitation 5Polymerase Chain Reaction 5Magnetic Resonance Spectroscopy 5Data Collection 5Carboplatin 5Amplified Fragment Length Polymorphism Analysis 5liposomal doxorubicin 4Geriatric Assessment 4Bevacizumab 41-dodecylpyridoxal 4Ultrasonography 3Trabectedin 3Therapeutics 3Poly(ADP-ribose) Polymerase Inhibitors 3Phlebotomy 3Observation 3Neoadjuvant Therapy 3Microarray Analysis 3Laparoscopy 3Gene Expression Profiling 3Flow Cytometry 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Ovarian Neoplasms × Poly(ADP-ribose) Polymerase Inhibitors × Clear all
NCT04724031 2023-03-14

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Hellenic Cooperative Oncology Group

Unknown
150 enrolled
Gynecologic

Ovarian Neoplasms

NCT05044091 2021-09-14

HOPEI

Jiangsu Cancer Institute & Hospital

Unknown
100 enrolled
Gynecologic

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT04582552 2021-01-20

ROMP

Jiangsu Cancer Institute & Hospital

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡